CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015] On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 10 years ago You may also like 59:40 Vamorolone Clinical Trials in Duchenne (January 2019) 6 years ago Research & Clinical Trial Webinars,Webinars 44:17 Translarna® (ataluren) Development Update (January 2019) 6 years ago Research & Clinical Trial Webinars,Webinars 1:04:43 The Heart of the Matter – PPMD’s Research Priorities (December 2018) 6 years ago Research & Clinical Trial Webinars,Webinars 1:01:12 Engaging Families in Care Guideline Development (November 2018) 6 years ago Care Webinars,Research & Clinical Trial Webinars,Webinars 47:47 PolarisDMD: Phase 3 Clinical Trial of Edasalonexent, a Novel NF-kB Inhibitor (November 2018) 6 years ago Research & Clinical Trial Webinars,Webinars 56:15 An Update on Corticosteroids (October 2018) 6 years ago Care Webinars,Research & Clinical Trial Webinars,Webinars 44:29 Is Myostatin Still a Potential Therapeutic Target? (October 2018) 6 years ago Research & Clinical Trial Webinars,Webinars 1:00:51 Puberty and Duchenne (September 2018) 6 years ago Care Webinars,Webinars «1…1415161718…25»Page 16 of 25
by: Parent Project Muscular Dystrophy
